Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 251,011,424
  • Shares Outstanding, K 5,606,688
  • Annual Sales, $ 41,908 M
  • Annual Income, $ 9,616 M
  • 60-Month Beta 0.74
  • Price/Sales 5.98
  • Price/Cash Flow 15.06
  • Price/Book 3.73
Trade PFE with:

Options Overview

Details
  • Implied Volatility 23.50%
  • Historical Volatility 19.59%
  • IV Percentile 49%
  • IV Rank 15.56%
  • IV High 60.64% on 12/09/20
  • IV Low 16.65% on 06/11/21
  • Put/Call Vol Ratio 0.60
  • Today's Volume 136,693
  • Volume Avg (30-Day) 309,469
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 2,704,639
  • Open Int (30-Day) 2,633,262

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.07
  • Number of Estimates 5
  • High Estimate 1.22
  • Low Estimate 0.96
  • Prior Year 0.72
  • Growth Rate Est. (year over year) +48.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.03 +1.00%
on 09/16/21
51.86 -14.25%
on 08/18/21
-4.44 (-9.08%)
since 08/16/21
3-Month
38.70 +14.91%
on 06/18/21
51.86 -14.25%
on 08/18/21
+5.17 (+13.16%)
since 06/16/21
52-Week
33.36 +33.30%
on 02/26/21
51.86 -14.25%
on 08/18/21
+7.69 (+20.91%)
since 09/16/20

Most Recent Stories

More News
Fed reviews ethics policies after prolific trading uncovered

WASHINGTON (AP) — The Federal Reserve is reviewing the ethics policies that govern the financial holdings and activities of its senior officials in the wake of recent disclosures that two regional Fed...

$SPX : 4,473.75 (-0.16%)
$DOWI : 34,751.32 (-0.18%)
$IUXX : 15,515.91 (+0.08%)
FNMA : 0.9524 (+0.26%)
JNJ : 165.22 (-0.12%)
PFE : 44.47 (-0.67%)
PSX : 65.76 (-0.41%)
NetworkNewsAudio Lexaria Bioscience Corp. (NASDAQ: LEXX) Leading Out in Innovation of Hypertension Treatment

(MENAFN - Investor Brand Network) Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about...

LEXX : 6.14 (-1.13%)
PFE : 44.47 (-0.67%)
MRK : 71.97 (-1.15%)
AZN : 56.60 (+0.27%)
MRNA : 440.65 (+1.42%)
Lymphoproliferative Disorder Treatment Market Emerging Trends, Market Research, And Comprehensive Insights 2028

Research Nester released a report titled "" which delivers detailed overview of the global lymphoproliferative disorder treatment market in terms of market segmentation by route of administration, drug...

ATRA : 15.87 (-0.19%)
NOVN : 8.45 (-1.63%)
MRK : 71.97 (-1.15%)
BMY : 61.23 (-1.24%)
ABBV : 108.08 (+0.29%)
GILD : 71.33 (-0.60%)
AZN.LN : 8,141.000 (+0.20%)
PFE : 44.47 (-0.67%)
Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet

Amid rising coronavirus cases, PFE and MRNA are trying to make booster doses of their COVID-19 vaccine available for US citizens. An FDA meeting is scheduled tomorrow to discuss Comirnaty's booster dose....

AZN : 56.60 (+0.27%)
JNJ : 165.22 (-0.12%)
PFE : 44.47 (-0.67%)
MRNA : 440.65 (+1.42%)
NVAX : 237.27 (+2.14%)
BNTX : 372.65 (+4.90%)
Neuroblastoma Drugs Market By Delivery, Type, Systems, End-User 2028

Research Nester published a report titled "- Global Demand Analysis and Opportunity Outlook 2020-2028" which delivers detailed overview of the neuroblastoma drugs market in terms of market segmentation...

CLRB : 0.9901 (+1.03%)
PFE : 44.47 (-0.67%)
LLY : 231.04 (-1.15%)
AZN.LN : 8,141.000 (+0.20%)
TEVA : 8.95 (-0.22%)
BMY : 61.23 (-1.24%)
MGNX : 20.99 (-23.76%)
JNJ : 165.22 (-0.12%)
Ophthalmology Equipment Market Expected Growth and its Factors, CAGR, Industry Size, Business Prospects and Forecast 2029

Research Nester published a report titled ": Global Demand Analysis & Opportunity Outlook 2029" which delivers detailed overview of the global ophthalmology equipment market in terms of market segmentation...

NVS : 84.38 (-0.82%)
CZMWY : 234.0000 (-0.64%)
HOCPY : 173.9590 (+0.74%)
PFE : 44.47 (-0.67%)
ABBV : 108.08 (+0.29%)
SNPHY : 15.4700 (+1.84%)
TOPCF : 17.9925 (-2.66%)
FDA strikes cautious tone ahead of vaccine booster meeting

WASHINGTON (AP) — Influential government advisers will debate Friday if there's enough proof that a booster dose of Pfizer's COVID-19 vaccine is safe and effective — the first step toward deciding...

PFE : 44.47 (-0.67%)
JNJ : 165.22 (-0.12%)
The Ten Top Stock Holdings Of Joel Greenblatt

Joel Greenblatt is an American investor, hedge fund manager and author. He is the founder of Gotham Capital and has also come up with many books on investing that detail his knowledge and tactics of nailing...

AMAT : 144.09 (+2.03%)
TGT : 246.95 (+1.15%)
ORCL : 87.25 (-0.55%)
PFE : 44.47 (-0.67%)
WMT : 145.03 (+0.33%)
FB : 373.06 (-0.23%)
GOOGL : 2,872.20 (-0.57%)
AAPL : 148.79 (-0.16%)
AMZN : 3,488.24 (+0.36%)
MSFT : 305.22 (+0.13%)
Axsome's (AXSM) Migraine Drug AXS-07 NDA Gets FDA Acceptance

Axsome (AXSM) is seeking approval for its key pipeline candidate, AXS-07, as a potential acute treatment for migraine.

PFE : 44.47 (-0.67%)
VRTX : 187.10 (-0.93%)
AXSM : 28.53 (+2.92%)
HRMY : 37.10 (+2.06%)
Markets Melt Down on Profit Taking, Not Economic Logic: 5 Picks

We have narrow down the search to five stocks that have provided double-digit returns year to date. These are: HPQ, LKQ, KSS, M and X.

HPQ : 28.04 (+0.32%)
PFE : 44.47 (-0.67%)
M : 22.12 (+3.80%)
KSS : 53.34 (+1.74%)
X : 25.39 (-1.09%)
LKQ : 52.24 (-0.80%)
BNTX : 372.65 (+4.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

3rd Resistance Point 45.92
2nd Resistance Point 45.46
1st Resistance Point 44.96
Last Price 44.47
1st Support Level 44.00
2nd Support Level 43.54
3rd Support Level 43.04

See More

52-Week High 51.86
Fibonacci 61.8% 44.79
Last Price 44.47
Fibonacci 50% 42.61
Fibonacci 38.2% 40.43
52-Week Low 33.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar